Media Contact
Kelly Zitlow, 847-858-5230
kelly.zitlow@waterstreet.com

Key Surgical Announces Acquisition

Key Surgical LLC, a leading global provider of sterile processing and operating room supplies, announced today that it has acquired Sarasota, Fla.-based Encompas Unlimited to expand the company’s endoscopy product offering.

Encompas is the second acquisition that Key Surgical has completed since it merged with Interlock Medizintechnik GmbH last year to become a leading provider to hospitals and surgical centers around the world.  Founded more than 30 years ago, Encompas specializes in manufacturing, assembling, and distributing a range of endoscopy accessories and supplies.  Key Surgical will incorporate Encompas’ endoscopy supplies into its portfolio of more than 3,000 products used by hospitals and surgery centers for patient procedures, as well as to clean and sterilize their surgical instrumentation.

Brian O’Connell, president and chief operating officer, Key Surgical, said, “We are excited to broaden our offering to our customers and their patients with the addition of Encompas.  The company has an excellent reputation for offering high-quality products, and we are excited to build on Key Surgical’s existing presence in the growing endoscopy market.”

Encompas will become part of Key Surgical and its products will be available directly from Key Surgical by the end of July.

About Key Surgical

Key Surgical is a leading global provider of sterile processing and operating room supplies. The company offers a broad suite of thousands of products and supplies focused on instrument reprocessing, operating room, and patient procedures to over 10,000 facilities in 70 countries. Headquartered in Eden Prairie, Minnesota, Key Surgical is a company of Water Street Healthcare Partners, a strategic investor focused exclusively on the health care industry. For more information, visit keysurgical.com.

Expand

Water Street Completes Premise Health Sale

Water Street announced today that it has completed the sale of Premise Health to OMERS Private Equity. Headquartered in Brentwood, Tenn., Premise Health is the nation’s leading direct health care access company.

Water Street partnered with Walgreen Co. in 2014 to invest in its onsite health care business subsidiary, Take Care Employer Solutions. The firm simultaneously merged the business with CHS Health Services and transitioned it to a standalone company, Premise Health.  Over the next four years, Water Street facilitated three more strategic acquisitions and invested in a state-of-the-art technology platform to extend Premise Health’s onsite model to near-site health centers and virtual health.

Since partnering with Water Street, Premise Health has expanded its national footprint to more than 600 health and wellness centers across 44 states, Guam and Puerto Rico.  The company has grown to serve more than 275 U.S. corporations, including many of the Fortune 1000, and employ more than 4,500 people.

“Together with Water Street, we have led an aggressive strategy to successfully position Premise Health as the leading direct health care access provider to U.S. employers,” said Stu Clark, chief executive officer, Premise Health.  “Premise Health is truly the gateway that is connecting companies, employees and their family members to phenomenal care so they can live healthier, more productive lives.”

Ned Villers, partner, Water Street, added, “Our partnership with Walgreens and the Premise management team created the opportunity to transform two competitors into an industry leader that is changing the future of employer health care.  We are pleased that our collective expertise and experience resulted in outstanding growth for the company and a sale that will deliver an exceptional return to our investors.

Financial terms of the sale are not being disclosed.

About Premise Health

Premise Health is a leading direct health care access company pioneering new models to deliver powerfully effortless health care. With more than 50 years of experience, Premise Health delivers unmatched quality, access and value through more than 600 health and wellness centers in 44 states, Guam and Puerto Rico. The company serves more than 275 of the nation’s most innovative organizations, including a significant number of Fortune 1000 companies.

Premise Health believes that the future of health care is unrivaled access to phenomenal care that costs less for clients, members and their dependents. It delivers that future today through three access points – onsite health, near-site health, and 24/7 virtual health. It also serves as the health care gateway for members and dependents, connecting them not only to its own robust and comprehensive provider network but also to the broader health care ecosystem. The result is a member experience that makes it easy to be seen anytime and anywhere.

For more information on Premise Health, visit www.premisehealth.com.

Expand

MedPlast Completes Acquisition and Unveils New Name

MedPlast, LLC announced today that the company has completed its previously announced acquisition of Integer Holding Corporation’s Advanced Surgical and Orthopedics (“AS&O”) business.  MedPlast also announced that it will rebrand under the name, Viant, to reflect the company’s new strategic direction.

“Today marks an exciting day for our company.  The addition of Integer’s business expands our capabilities and offerings, and enables us to achieve our goal of being a full-service supplier to our customers,” said MedPlast Chief Executive Officer Brian King.  “Our new name, Viant, represents our dedication to our customers and to the patients that our customers serve; and is indicative to our commitment that ‘we’re in it for life.’ We could not be more pleased to rebrand as Viant in conjunction with the close of this newest acquisition.”

MedPlast has bolstered its portfolio of end-to-end solutions in the medical technology space with three acquisitions in the past 15 months. With the company’s most recent acquisition of Integer’s AS&O business, MedPlast doubles in size to nearly $1 billion in sales, expands its metals capabilities and extends its global footprint into Europe. The acquisition also strengthens MedPlast’s ability to vertically integrate and simplify the supply chain for its customers.

In addition to rebranding as Viant, MedPlast announced that its corporate headquarters will move to Foxborough, Massachusetts, placing it in a major medical device hub near many of its customers. Since Water Street and JLL’s investment in MedPlast in 2016, the company’s employee base has doubled to nearly 6,000 associates located across the United States, Central America, Europe, and Asia.

To learn more about MedPlast and its new name, Viant, visit, www.viantmedical.com.

About Viant (formerly MedPlast)

At Viant, we focus on providing end-to-end solutions for medical device OEMs. Our deep materials expertise, including metals—combined with our experience in engineering, manufacturing, assembly, packaging, and sterilization —allows us to bring our customers’ medical technology solutions to market. We have 25 worldwide locations and are well-positioned to serve our OEM partners.  For more information, visit www.viantmedical.com.

 

Expand

Water Street to Divest Premise Health

Direct health care company Premise Health today announced global investment firm OMERS will become its new lead investor beginning in mid-July, following four years of partnership with Water Street Healthcare Partners.

For Premise Health, which partners with organizations to address the health needs of their employee and dependent populations, this announcement marks the next step forward as it grows to meet demand for greater health care access, according to Premise CEO Stu Clark.

“Over the last four years, we have significantly expanded and evolved our model to deliver unrivaled access to high-quality care, offering a seamless member experience and exceptional value,” Clark said. “Now, we are poised to continue that progress with support and capital from a global partner known for its long-term investment approach, which aligns perfectly with our vision and commitment to our clients, members and their families.”

Water Street and Premise worked together closely to select OMERS as the company’s new investment partner, and Premise’s executive team will continue to lead the company, Clark added.

Ned Villers, partner, Water Street, commented, “When we partnered with Walgreens and the management team to create Premise Health, our vision was to transform Premise into the national leader in employer health care. We are proud of the tremendous value that Premise Health brings to the health care system today and believe that the company is ideally positioned to continue its strong growth in the future.”

OMERS is one of Canada’s largest defined benefit pension plans, with more than $95 billion in net assets, as of December 31, 2017. Other examples of OMERS Private Equity’s healthcare investments include dermatology provider Forefront Dermatology, dental services provider Great Expressions, outpatient physical therapy and home health provider CBI Health Group, and outpatient rehabilitation services provider Accelerated Rehabilitation Centers.

“Our approach to investment is a patient one, with a focus on growing businesses by providing long-term capital and supporting management,” said Tim Patterson, OMERS managing director. “We’re pleased to partner with Premise Health to pioneer new solutions to enhance health care experiences, while lowering the overall cost.”

Rising health care costs remain a challenge for many organizations. Average annual employer contributions to premiums for family coverage increased 48 percent between 2007 and 2017, from $8,824 to $13,049 per family, according to the Kaiser Family Foundation 2017 Employer Health Benefits Report.

Patterson added that together, Premise and OMERS have “a tremendous opportunity to offer organizations a different approach to health care and make a difference for millions of people.”

Harris Williams & Co. acted as the merger and acquisition advisor to Premise Health for this transaction.

ABOUT PREMISE HEALTH

Premise Health is the leading direct healthcare company pioneering new models to deliver powerfully effortless healthcare. With more than 50 years of experience, Premise Health delivers unmatched quality, access and value through more than 600 health and wellness centers in 44 states, Guam and Puerto Rico. The company serves more than 275 of the nation’s most innovative organizations, including a significant number of Fortune 1000 companies.

Premise Health believes that the future of healthcare is unrivaled access to phenomenal care that costs less for clients, members and their dependents. It delivers that future today through three access points – onsite health, nearsite health, and 24/7 virtual health. It also serves as the healthcare gateway for members and dependents, connecting them not only to its own robust and comprehensive provider network but also to the broader healthcare ecosystem. The result is a member experience that makes it easy to be seen anytime and anywhere.

For more information on Premise Health, visit www.premisehealth.com.

 

Expand

Mark Thierer Appointed to Chairman of Life Sciences Platform

Water Street and JLL Partners announced today that they have recruited Mark Thierer to chairman and Jim Lang to CEO of their rapidly growing life sciences services platform. The longtime health care leaders will spearhead the platform’s ongoing expansion of solutions that improve the speed and success of bringing complex therapies to market.

Mr. Thierer brings more than 30 years of health care leadership experience to the organization, which is comprised of the industry’s premier service providers including Dohmen Life Science Services, The Access Group, Alliance Life Sciences, Health Strategies Group, Triplefin and Patient Experience Project. Mr. Lang, who previously served as executive chairman of the growing company, has been instrumental in bringing together these businesses over the past six months to build a platform of end-to-end services for life sciences companies.

“I am honored that the board has entrusted me with continuing to build this innovative organization,” said Mr. Lang. “We are integrating science and commercialization in an entirely new way to position therapies for success across all major stakeholders – regulators, payers, providers and patients. The addition of Mark to our board will be hugely beneficial to advancing our goal of becoming the partner of choice for biopharmaceutical and medical device companies.”

Mr. Thierer added, “I’m excited to join this fast-growing organization that is reshaping the life sciences services landscape.  It is a unique opportunity to be part of building a new solution that is addressing a fundamental shift in our industry toward patient-centric, value-based health care.”

About Mark Thierer

Mark Thierer most recently served as CEO of OptumRx , where he oversaw all Optum pharmacy care services, including the management of pharmacy benefits, the pharmacy network, and home delivery pharmacy and specialty pharmacy programs. Prior to this role, Mr. Thierer served as chairman and CEO of Catamaran, which was one of America's largest pharmacy benefit management companies and merged with OptumRx in 2015. Earlier in his career, Mr. Thierer served as president, CEO and chairman of SXC Health Solutions, which merged with Catalyst Health Solutions to create Catamaran. During his time as CEO of SXC Health Solutions, the company recorded a compound annual growth rate of 50 percent and a 50-fold increase in shareholder value.  He received a bachelor’s degree in finance at the University of Minnesota and a master’s in business administration from Nova Southeastern University.

About Jim Lang

Jim Lang has more than 25 years of experience leading, advising and funding mission-driven health care companies.  Prior to his current role, he served as CEO of Decision Resources Group, which he built into a leading health care data and analytics company via 17 acquisitions. Previously, Mr. Lang was CEO of IHS CERA, now IHS Markit, a recognized leader in energy insight products and services.  Before that, Mr. Lang spent 17 years building and leading Strategic Decisions Group (SDG), a premier strategy consultancy, where he advised boards and c-suites of the Global 2000.  Mr. Lang’s advisory and transformation work has created multiples of billions of dollars in share value across those companies.  He also spearheaded SDG’s successful sale, including its large life sciences practice to IMS Health (now IQVIA).  Mr. Lang is an active private investor in health care and has served on more than a dozen private and public company boards.   He holds a bachelor’s degree in electrical and computer engineering from the University of New Hampshire and a master’s in business administration from the Dartmouth Tuck School of Business.

About the Company

Water Street Healthcare Partners and JLL Partners, two strategic investment firms specializing in health care, have built the life sciences industry’s leading independent provider of services through a series of strategic acquisitions.  The firms recently completed the acquisition of Triplefin, which joins Dohmen Life Science Services, The Access Group, Health Strategies Group, Alliance Life Sciences and the Patient Experience Project.  As one entity, the businesses offer customers a portfolio of comprehensive solutions, including channel, market access, patient support and compliance to improve the speed and success of bringing complex therapies to market. Together, they employ nearly 1,500 global professionals who serve more than 300 of the industry’s top biopharmaceutical and medical device companies.

 

 

Expand

MedPlast Appoints John Greisch to Chairman

MedPlast, LLC, a leading global services provider to the medical device industry, announced today that its board of directors has appointed John J. Greisch as chairman, effective immediately.  The longtime health care executive, who recently served as president and chief executive officer of Hill-Rom Holdings, Inc., joins MedPlast’s board as the company continues to expand its suite of manufacturing solutions.

During his eight years of leadership at Hill-Rom, Mr. Greisch, 62, was instrumental in transforming the company’s business portfolio, expanding its global footprint and advancing its position as a global medical device leader while delivering an increase in enterprise value of over $6 billion.  Prior to Hill-Rom, Mr. Greisch served in senior leadership positions with Baxter International Inc., including president of the company’s International Operations, chief financial officer and president of its BioScience division. He currently serves on the board of directors of Catalent, Inc., Idorsia Pharmaceuticals Ltd. and The Ann & Robert H. Lurie Children’s Hospital of Chicago.

“I could not be more pleased to have someone with John’s background and experience become chairman of our board,” stated Brian King, CEO, MedPlast.  “Since my first meeting with John, I have been energized by his thoughtful and dedicated manner.  I am confident that John is going to bring a positive and enthusiastic approach to the MedPlast team, and I am very happy to have him join our board.”

Mr. Greisch’s appointment follows MedPlast’s agreement to acquire the Advanced Surgical and Orthopedics business of Integer Holdings Corporation. The acquisition, which is expected to close in the third quarter of 2018, will bolster MedPlast’s suite of manufacturing services and transform the company into one of the world’s leading outsourced contract manufacturers of medical devices. It is the third acquisition that MedPlast has facilitated since partnering in 2016 with Water Street Healthcare Partners and JLL Partners, two strategic investment firms specializing in the health care industry.  Water Street and JLL were instrumental in recruiting Mr. Greisch to the chairman position.

“I am honored to join the board at this exciting point in MedPlast’s evolution,” said Mr. Greisch. “Through my years of leading and growing one of the world’s premier medical technology companies, I have seen the need for a comprehensive services provider like MedPlast. I look forward to working with Brian and the board to build on MedPlast’s strong foundation and to position the company as the leading solutions partner to medical device companies.”

About MedPlast

At MedPlast, we focus on providing end-to-end solutions for medical device OEMs. Our deep materials expertise – combined with our experience in engineering, manufacturing, assembly, packaging, and sterilization – allows us to bring our customers’ medical technology solutions to market.  We have 15 locations including low-cost facilities in Costa Rica, China, Mexico, and Puerto Rico.  For more information on MedPlast, visit www.medplastgroup.com.

Expand

MedPlast to Acquire Integer Business

Integer Holdings Corporation (“Integer”) (NYSE: ITGR), a leading medical device outsource manufacturer, today announced that it has entered into an agreement to sell its Advanced Surgical and Orthopedics (“AS&O”) product lines to MedPlast, LLC (“MedPlast”), a leading global services provider to the medical device industry, for $600 million in cash.

The transaction is expected to close in the third quarter of 2018 and is subject to customary closing conditions, including U.S. and foreign antitrust clearances.

“Integer is a global leader in medical device outsourcing, with an unmatched breadth of design, development and manufacturing capabilities,” said Joe Dziedzic, Integer’s president and chief executive officer. “After this divestiture and paying down debt with the proceeds, we expect to be a $1.2 billion company with higher margins, increased net earnings, greater returns on invested capital, and significantly lower debt leverage. This increased financial flexibility will enable us to grow our leadership position in our Cardio & Vascular and Cardiac & Neuromodulation product lines as we partner with customers to deliver life-changing innovation.”

Integer’s AS&O capabilities will bolster MedPlast’s portfolio of manufacturing solutions and transform MedPlast into one of the world’s leading outsourced contract manufacturers of medical devices. In addition to expanding MedPlast’s offering into a broad range of metals manufacturing capabilities, including machining, stamping, coating and metal forming, it will further strengthen MedPlast’s front-end design, development and prototyping services. Once complete, the acquisition will double MedPlast’s size to nearly $1 billion in sales, as well as its global footprint, with an expanded presence in Europe. MedPlast will employ nearly 6,000 engineers, technicians and assembly workers at manufacturing facilities across Asia, Central America, Europe and the United States.

“MedPlast is incredibly excited about the addition of Integer’s AS&O capabilities to our existing platform,” said MedPlast Chief Executive Officer Brian King. “This acquisition will further broaden our offerings and strengthen our ability to provide our customers with innovative solutions to meet their challenging needs. It also will provide additional scale and new growth opportunities for MedPlast. We are excited to be working with the AS&O team and look forward to collectively growing our company and continuing to deliver outstanding service to our customers.”

MedPlast’s agreement to acquire Integer’s AS&O business is the third acquisition MedPlast has facilitated in the past year. In 2017, MedPlast acquired Vention Medical’s Device Manufacturing Services business and Coastal Life Technologies to extend its portfolio of services into assembly and packaging. The strategic acquisitions follow MedPlast’s partnership in 2016 with Water Street Healthcare Partners and JLL Partners, two strategic investment firms specializing in the health care industry.

The transaction does not include Integer’s Portable Medical product line, which will remain a part of Integer.

Piper Jaffray & Co. is serving as financial advisor to Integer while Hodgson Russ LLP is serving as legal advisor.

 

Expand

Water Street Invests in PEP

Water Street announced today with JLL Partners that it has invested in The Patient Experience Project (PEP), a full-service, patient-centric healthcare marketing and communications agency based in Saratoga Springs, New York. Water Street and JLL will combine PEP with their global life sciences platform.

"This is a natural next chapter for an expanding and innovative business like PEP,” said PEP Founder and President Dan Bobear. “It will give us the resources we need to bring additional services to our clients, advance our mission to improve the patient experience, and take the agency to the next level.”

PEP will continue to operate under its existing name and management team from its locations in Saratoga Springs and Chicago. Bobear will remain as PEP’s president and will manage the firm and lead its operations in the same capacity he has since its inception in 2012. “For our clients and our employees, it will be business as usual,” Bobear added.  The agency plans to continue to hire and, in fact, anticipates adding a number of new employees in 2018.

“Water Street and JLL have a proven track record of growing companies by investing in infrastructure, technology, and human resources to enable that growth,” said Bobear. “I am confident that PEP and our clients will see great benefit from their experience and expertise.”

Water Street and JLL have significantly expanded their life sciences platform since forming it last year through the merger of Alliance Life Sciences and Health Strategies Group with The Access Group. The firms recently added Triplefin and Dohmen Life Science Services to the platform to extend its solutions to patient-centered services.

With the addition of PEP, the platform will offer customers a comprehensive portfolio of offerings, including channel, market access, patient support, marketing, communications, and regulatory solutions to improve the speed and success of bringing complex therapies to market. It will employ nearly 1,500 global professionals who will serve more than 300 of the industry’s top biopharmaceutical and medical device companies.

“We are thrilled to have PEP, one of the fastest growing healthcare agencies in the country, join our platform. We share their commitment to the patient being at the center of everything we do,” said Jim Lang, executive chairman of the life sciences platform. “PEP offers leading-edge approaches that enable life sciences companies to create unique solutions for patient support in complex and rare therapies. Together, we can offer patients comprehensive support, including using evidence/outcomes-based frameworks to show the value of their treatment.”

About the Patient Experience Project PEP is a full-service, patient-centric communications firm serving the healthcare, pharmaceutical, diagnostic, and biotechnology industries. PEP has offices in Saratoga Springs, New York, and Chicago, Illinois. PEP’s nationally recognized approach centers around the collaboration with the foremost disease experts—patients themselves—to co-create authentic programs and content for patients, caregivers, and healthcare professionals. PEP was named to the Inc. 5000 in 2017, a list of the fastest-growing private companies in America. For more information, visit the-pep.com.

 

Expand

Water Street Announces Life Sciences Acquisition

Water Street announced today that it has signed an agreement to acquire Triplefin with JLL Partners.  An industry leader in patient support for more than 30 years, Triplefin is the latest company to join the investment firms’ growing life sciences commercialization services platform.

The addition of Triplefin to the life sciences platform will significantly expand the platform’s patient-centered capabilities. Headquartered in Cincinnati, Ohio, Triplefin specializes in pharmaceutical hub services, including its Hub-Lite® and co-pay programs which are dedicated to improving the patient experience.  The company’s suite of digital capabilities, including its industry-leading Rx365® technologies, coupled with its customer service expertise, provides patients with personalized support to enhance their therapeutic success.

“We are thrilled to add this fast-growing, customer-focused business to our platform,” said Jim Lang, executive chairman of the platform.  “Triplefin brings to us a powerful combination of innovative solutions.  Our platform now offers customers end-to-end, best-in-class solutions that will help them successfully engage with every major constituent — regulators, payers, providers, channel partners and patients – to maximize the impact of new therapies.  The era of value-based, patient-centered solutions has come, and we aspire to be the industry’s partner of choice.”

Triplefin follows the platform’s recent acquisitions of Dohmen Life Science Services in March, as well as The Access Group, Health Strategies Group and Alliance Life Sciences over the past 18 months.  Together, these businesses will offer customers a comprehensive portfolio of solutions, including channel, market access, patient support and compliance to improve the speed and success of bringing complex therapies to market. As one entity, the newly expanded platform will employ nearly 1,500 global professionals who will serve more than 300 of the industry’s top biopharmaceutical and medical device companies.

“These are truly exciting times for Triplefin as we continue to experience unparalleled growth,” said Sandy Piscitello, president, Triplefin.  “Now, we move toward our next step of joining forces with Water Street and JLL’s life sciences platform to strengthen our position in the marketplace and bring our clients an exceptional portfolio of commercialization solutions.”

Dale Smith, chairman & CEO of Triplefin’s current owner, H. D. Smith Holding Company, added, “We have been proud owners of Triplefin for the past five years and are excited to see the company enter its next chapter.  We chose JLL and Water Street as the best partners for Triplefin based on their strong track record of building market-leading companies that put employees and customers first.”

Triplefin will continue to operate under its existing name and management team. Sandy Piscitello will continue to lead Triplefin and report to Mr. Lang. The acquisition is expected to close by the end of the second quarter.  Financial details are not being disclosed.

About Triplefin

A market leader in patient support for more than 30 years, Triplefin delivers comprehensive hub services that improve patient access and adherence, including its patent-pending Rx365® suite of digital solutions. Triplefin's programs help thousands of patients with serious diseases, offering hope and improved well-being. Its associates are dedicated to providing an empathetic, caring experience throughout a patient’s journey. The company is headquartered in Cincinnati, Ohio.  For more information, visit www.triplefin.com.

 

Expand

Water Street Completes Sale of Sarnova

Water Street and Sarnova founder, Matthew D. Walter, announced today that they have completed the sale of Sarnova, the nation’s premier national distributor of health care products to the acute care and emergency medical services (EMS) markets.

Both Water Street and Mr. Walter will remain minority investors in the company.

Water Street partnered with Mr. Walter in 2008 to merge two leading specialty distributors – Bound Tree Medical and Tri-anim Health Services – to create Sarnova.  Over the next 10 years, Water Street facilitated eight strategic acquisitions to expand Sarnova’s suite of medical products and services.  It invested in the company’s infrastructure, enhanced its technology and extended its national footprint. Today, Sarnova is the leading provider of products and services that address the full continuum of care from pre-hospital through acute care.

Over the course of Sarnova’s 10-year partnership with Water Street, the company doubled its customer base to serve more than 30,000 of the nation’s hospitals, surgical centers and EMS providers.  It grew its revenues more than 50 percent and nearly doubled its employees to more than 600 people.

“Our relationship with Water Street and Matt Walter has been outstanding, building Sarnova into a market leader in the EMS and acute care markets,” said Jeff Prestel, CEO, Sarnova.  “We view the acquisition by Patricia Industries as a catalyst for Sarnova’s next leap in becoming the very best company in specialty medical sales and distribution and are excited that Water Street and Matt will continue to be part of supporting our growth.”

Chris Sweeney, partner, Water Street, added, “It has been an honor to work with Sarnova’s team over the past ten years.  The company has grown on all fronts – and most importantly in the quality and depth of products and services it offers customers.  We are pleased to have found a strong home for Sarnova in Patricia Industries.”

Patricia Industries, which is part of the Swedish Industrial Holding company Investor AB, will be the majority owner of Sarnova.

About Sarnova

Sarnova is the leading national specialty distributor of healthcare products in the emergency medical services (EMS) and acure care markets.  The company is comprised of four major business units: Bound Tree Medical, Cardio Partners, Emergency Medical Products and Tri-anim Health Services.  For more information, visit www.sarnova.com

 

Expand